Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington, USA.
Kidney Research Institute, University of Washington, Seattle, Washington, USA.
Clin Transl Gastroenterol. 2024 Nov 1;15(11):e00775. doi: 10.14309/ctg.0000000000000775.
Cirrhosis affects all structures of the kidney, in particular the tubules, which are responsible for secretion of protein-bound metabolites and electrolyte/water homeostasis. Yet, prevailing assessments of kidney function focus solely on glomerular filtration rate (GFR), which may incompletely reflect these processes. We sought to characterize markers of tubular function, injury, and viability in patients with and without cirrhosis.
We recruited outpatients undergoing liver transplantation evaluation for a collection of plasma and 24-hour urine, matching by GFR to control participants without cirrhosis. We measured urinary kidney injury molecule-1, a marker of proximal tubular injury, as well as epidermal growth factor (EGF), a marker of viability necessary for tubular epithelial cell proliferation after injury. We also estimated secretory clearance by measuring several highly secreted endogenous metabolites in urine and plasma.
We recruited 39 patients with cirrhosis (mean model for end-stage liver disease 17 ± 4, Child-Pugh 8 ± 2, estimated glomerular filtration rate 66 ± 20 mL/min/1.73 m 2 ) and 58 GFR-matched controls without cirrhosis (estimated glomerular filtration rate 66 ± 21 mL/min/1.73 m 2 ). Urinary kidney injury molecule-1 was 4.4-fold higher than controls (95% confidence interval: 2.9-6.5), and EGF averaged 7.41-fold higher than controls (95% confidence interval: 2.15-25.53). We found that of 8 solutes, 5 had significantly greater kidney clearance in cirrhosis (1.3-2.1-fold higher): indoxyl sulfate, p-cresol sulfate, pyridoxic acid, tiglylglycine, and xanthosine.
Cirrhosis was characterized by molecular signs of tubular injury in stable outpatients without acute kidney injury, accompanied by largely preserved tubular secretory clearance and greater signs of tubular viability. Within the limitations of the study, this suggests a phenotype of chronic ischemic injury but with initial preservation of tubular function in cirrhosis.
肝硬化会影响肾脏的所有结构,尤其是负责分泌蛋白结合代谢物和电解质/水稳态的肾小管。然而,目前对肾功能的评估主要集中在肾小球滤过率(GFR)上,而 GFR 可能无法完全反映这些过程。我们试图描述肝硬化患者和非肝硬化患者肾小管功能、损伤和活力的标志物。
我们招募了正在接受肝移植评估的门诊患者,收集了他们的血浆和 24 小时尿液,并按照 GFR 与无肝硬化的对照组相匹配。我们测量了尿肾损伤分子-1(一种近端肾小管损伤的标志物)和表皮生长因子(EGF),EGF 是肾小管上皮细胞损伤后增殖所必需的存活标志物。我们还通过测量尿液和血浆中几种高度分泌的内源性代谢物来估计分泌清除率。
我们招募了 39 名肝硬化患者(平均终末期肝病模型 17 ± 4,Child-Pugh 8 ± 2,估计肾小球滤过率 66 ± 20 mL/min/1.73 m 2 )和 58 名 GFR 匹配的无肝硬化对照组(估计肾小球滤过率 66 ± 21 mL/min/1.73 m 2 )。尿肾损伤分子-1 比对照组高 4.4 倍(95%置信区间:2.9-6.5),EGF 平均比对照组高 7.41 倍(95%置信区间:2.15-25.53)。我们发现,在 8 种溶质中,有 5 种在肝硬化患者中的肾清除率明显更高(高 1.3-2.1 倍):吲哚硫酸、对甲酚硫酸、吡哆醛酸、丁二酰甘氨酸和黄嘌呤核苷。
在没有急性肾损伤的稳定门诊患者中,肝硬化的特征是肾小管损伤的分子标志物,同时伴有肾小管分泌清除率的显著增加和肾小管活力的增加。在研究的局限性内,这表明肝硬化存在慢性缺血性损伤表型,但肾小管功能最初保持完好。